Metabolic programs define dysfunctional immune responses in severe COVID-19 patients

Mostrar otras versiones (1)

It remains unclear why some patients infected with SARS-CoV-2 readily resolve infection while others develop severe disease. To address this question, we employed a novel assay to interrogate immune-metabolic programs of T cells and myeloid cells in severe and recovered COVID-19 patients. Using this...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Elizabeth A., Cascino, Katherine, Ordonez, Alvaro A., Zhou, Weiqiang, Vaghasia, Ajay, Hamacher-Brady, Anne, Brady, Nathan R., Sun, Im-Hong, Wang, Rulin, Rosenberg, Avi Z., Delannoy, Michael, Rothman, Richard, Fenstermacher, Katherine, Sauer, Lauren, Shaw-Saliba, Kathyrn, Bloch, Evan M., Redd, Andrew D., Tobian, Aaron AR, Horton, Maureen, Smith, Kellie, Pekosz, Andrew, D’Alessio, Franco R., Yegnasubramanian, Srinivasan, Ji, Hongkai, Cox, Andrea L., Powell, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491535/
https://www.ncbi.nlm.nih.gov/pubmed/32935120
http://dx.doi.org/10.1101/2020.09.10.20186064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491535/
https://www.ncbi.nlm.nih.gov/pubmed/32935120
http://dx.doi.org/10.1101/2020.09.10.20186064

Ejemplares similares